GLMD
NASDAQ · Biotechnology
Galmed Pharmaceuticals Ltd
$0.53
-0.03 (-5.18%)
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+3,148.6% upside
Low Target
$9.83
Average Target
$17.25
High Target
$23.67
Current Price
$0.53
Current
$0.53
$0.53
Target
$17.25
$17.25
$9.83
$17.25 avg
$23.67
Scenario Analysis
Bear Case
$9.83
1,751.2%
Low target
Base Case
$17.25
+3,148.6%
Avg target
Bull Case
$23.67
+4,357.6%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$1.65
-67.8% from high
52-Week Low
$0.41
+29.2% from low
Target vs 52W High
$17.25
+945.5% vs high
Next Earnings Report
Aug 26, 2026
11d
until earnings
EPS Est: $-0.40
Earnings in 11 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | +3.2% |
| AMGN | Hold | 43 | 49% | $190.87 | -53.8% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +162.6% |
| VRTX | Strong Buy | 37 | 81% | $438.34 | -13.8% |
| REGN | Buy | 37 | 70% | $76.80 | -90.4% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -53.9% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -43.8% |
| BIIB | Buy | 43 | 67% | $91.45 | -56.6% |